Skip to main content
Minerva Neurosciences, Inc. logo

Minerva Neurosciences, Inc. — Investor Relations & Filings

Ticker · NERV ISIN · US6033802058 LEI · 54930017PANCHC5LYH79 US Manufacturing
Open in API
Filings indexed 589 across all filing types
Latest filing 2015-09-24 Regulatory Filings
Country US United States of America
Listing US NERV

About Minerva Neurosciences, Inc.

https://www.minervaneurosciences.com/

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of product candidates for the treatment of central nervous system (CNS) diseases. The company's lead product candidate is roluperidone, which is being developed to treat the negative symptoms of schizophrenia. Minerva Neurosciences leverages its expertise in clinical development to design innovative trials with clinical endpoints aimed at demonstrating direct patient benefit.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated September 24, 2015. It announces a press release and an updated corporate presentation related to clinical trial updates for a product candidate. The document explicitly states that the press release and presentation are furnished as exhibits and are not filed for purposes of Section 18 of the Securities Exchange Act. The content is primarily an announcement of a press release and a presentation, not the full reports themselves. The document length is 3304 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this filing is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories and includes current reports like 8-Ks that announce events or releases without containing full financial data or detailed reports.
2015-09-24 English
8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details the entry into a material definitive agreement, namely a First Amendment to a Loan and Security Agreement, which is a financing-related event. There are no financial statements or comprehensive financial data presented, only the announcement of the amendment to the loan agreement. This fits the category of Capital/Financing Update (CAP) as it relates to changes in the company's financing arrangements.
2015-08-28 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content describes an update on a clinical trial patient screening count, which is an operational event rather than a financial report or management change. The document is short (2118 characters) and does not contain financial statements or detailed analysis. It is not an earnings release, annual report, or management report. It is not a certification or voting result. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2015-08-05 English
10-Q
Interim / Quarterly Report Q2 2015
2015-08-05 English
Regulatory Filings 2015
Regulatory Filings
2015-07-28 English
Regulatory Filings 2015
Regulatory Filings Classification · 95% confidence The document is a correspondence letter addressed to the SEC regarding a Registration Statement on Form S-3, requesting the SEC to declare the filing effective. It is a formal communication related to the effectiveness of a securities registration statement, not a financial report or detailed filing itself. The document length is short (1547 characters) and it does not contain financial data or report content. It is an announcement/request related to a regulatory filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory communications that do not fit other specific categories.
2015-07-24 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.